Evidence map›Paper›PMID 20012134›Full record

ArticleThe European journal of health economics : HEPAC : health economics in prevention and care2010

Colocteral cancer management and prevention policies in Greece.

Mary Geitona, Panos Kanavos

Abstract read
PubMed Publisher
In one paragraph

Article in The European journal of health economics : HEPAC : health economics in prevention and care, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. The dynamics of colorectal cancer management in 17 countries.The European journal of health economics : HEPAC : health economics in prevention and care · 2010
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Mary GeitonaDepartment of Economics, University of Thessaly, Korai 43, 38221 Volos, Greece. geitona@econ.uth.gr
Panos Kanavos

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Despite lower cancer mortality rates in Greece compared to other European countries, colorectal cancer (CRC) is the third most important cause of cancer mortality. Given the significant economic and societal impact of CRC in Greece, this paper focuses on CRC data resources, disease management and the existing prevention policies. Numerous initiatives have taken place for the collection of data and the creation of cancer registries, however, they currently remain incomplete. Despite universal access of the Greek population to health services provision, structural problems of the national health system have imposed organisational barriers to the geographical distribution of health resources. National invitational CRC screening programmes focusing on early detection of the disease as well as guidelines for its management are missing. All novel cancer treatments are fully reimbursed. Post-treatment surveillance guidelines for high-risk patients are very limited and depend solely on health providers' decisions. A National Cancer Plan (NCP) had been announced during the 2008-2012, but is still in the planning phases. Under the proposed NCP, the longevity of cancer data collection seems to be the critical step in monitoring and improving the performance of the health system. Detailed epidemiological data will give the possibility of constructing an effective prevention policy, will reduce socio-economic inequalities in the access to CRC treatment and lighten the differences observed in health outcomes. The full implementation of the NCP constitutes the most significant investment in cancer management that has ever taken place in Greece.

Indexed as

Health PolicyColorectal NeoplasmsFemaleGreeceHumansMaleMass ScreeningRegistries

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.